The cladribine conundrum: deciphering the drug's mechanism of action.
about
Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice.Drug transporter pharmacogenetics in nucleoside-based therapies.Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies.Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.Cladribine to Treat Relapsing Forms of Multiple Sclerosis.
P2860
The cladribine conundrum: deciphering the drug's mechanism of action.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The cladribine conundrum: deciphering the drug's mechanism of action.
@ast
The cladribine conundrum: deciphering the drug's mechanism of action.
@en
type
label
The cladribine conundrum: deciphering the drug's mechanism of action.
@ast
The cladribine conundrum: deciphering the drug's mechanism of action.
@en
prefLabel
The cladribine conundrum: deciphering the drug's mechanism of action.
@ast
The cladribine conundrum: deciphering the drug's mechanism of action.
@en
P2860
P1476
The cladribine conundrum: deciphering the drug's mechanism of action.
@en
P2093
Dennis M Peffley
Patricia Hentosh
P2860
P356
10.1517/17425250903393745
P407
P577
2010-01-01T00:00:00Z